![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Oxford Finance Provides $8M Senior Debt Facility to BiO2 Medical
Oxford Finance Provides $8M Senior Debt Facility to BiO2 Medical
February 1, 2016
Oxford Finance has closed an $8 million senior secured term loan with BiO2 Medical.
The funds are being used to support the company as it awaits FDA clearance and the anticipated U.S. launch of its Angel catheter, both of which are expected this year.
The Angel catheter is designed to give physicians the control to provide temporary, prophylactic pulmonary embolism protection at the patient’s bedside, the company says. — Jonathon Shacat
Upcoming Events
-
21Oct